Oncology17 Jun 2011
A new update by the Food and Drug Administration (FDA) has warned the physicians and the consumers that continued use of Pioglitazone, an anti-diabetes medicine, for more than one year may be linked with an increased risk of bladder cancer. The FDA has announced that information on the drug;s label as well as the patient medical guide will soon be revised to include the link between the medicine and bladder cancer. Pioglitazone is an anti- diabetic drug used in the treatment of type II diabetes...
Oncology7 Jun 2011
A recent breakthrough in cancer research has brought out a new drug ‘zoledronic acid’ that may prevent lung cancer from spreading in the early stages. Lung cancer, the carcinoma of the lungs is one of the commonest forms of cancer which characterized by the uncontrolled growth of cells in the lung tissues. Symptoms of lung cancer include excessive weight loss, shortness of breath and persistent cough. Every year about 1.3 million people die of lung cancer worldwide. A recent research has...
Oncology15 Jun 2011
A research from Lund University explains that people who are married to cancer patients or those who are living with them are at a greater risk of being diagnosed with diseases. Cancer refers to any malignant growth or tumor caused by abnormal and uncontrolled cell division. Cancer may spread to other parts of the body through the blood stream. This disease is not only fatal for the person suffering from it, but it can also be a reason for increased illnesses in the patient’s spouse according...
Oncology4 Jun 2011
Findings of a new study indicate that cancer therapies like chemotherapy and endocrine therapy may affect balance in breast cancer survivors. Breast Cancer is the carcinoma of breast tissues that initiates from the milk ducts. Also known to be the most curable category of cancers, today breast cancer is one of the most common malignancies in women worldwide, especially in the United States of America. Chemotherapy and Endocrine therapy form the part of the treatment procedures generally...
Oncology12 May 2011
Prostate cancer is the second most common cancer in men over the age of 75 with over 230,000 cases detected every year. However, it is a slow growing tumor and only certain types endanger a man’s life. Moreover, in men with a localized form of cancer, the side effects of treatment may overweigh its benefits and treating the cancer may do more harm than good. Therefore, it is important for the doctors to differentiate between the serious cancers from the insignificant. Using two-dimensional,...
- Drug Used to Treat Arthritis also Effective against Breast Cancer
- Gene Responsible for Rhabdoid Tumors Identified
- Chinese Herbal Injection for Non-Small Cell Lung Cancer
- Radiation Therapy works well for HIV-Positive Head and Neck Cancer Patients
- Avoidable risk factors of breast cancer
- Breast Self Examination - beneficial or not